Gilead Sciences to Present at Two Upcoming Investor Conferences
- 2013 Morgan Stanley Global Healthcare Conference on September 9^th -
- Baird’s 2013 Healthcare Conference on September 10^th -
- Webcast Available Through Gilead Corporate Website -
Morgan Stanley Global Healthcare Conference 2013 Baird's Health Care
FOSTER CITY, Calif. -- September 6, 2013
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company will be
webcasting its corporate presentation at two upcoming investor conferences:
the 2013 Morgan Stanley Global Healthcare Conference and Baird’s 2013
Healthcare Conference, both taking place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will
provide an overview of the company at the Morgan Stanley conference on Monday,
September 9 at 11:10 a.m. Eastern Time (ET) and the Baird conference on
Tuesday, September 10 at 10:15 a.m. ET.
To access the live webcast or a replay via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15 minutes
prior to the start of the presentation to ensure adequate time for any
software download that may be necessary to listen to the webcast. The replay
will be available for 14 days following the presentation.
Gilead Sciences is a biopharmaceutical company that discovers, develops and
commercializes innovative therapeutics in areas of unmet medical need. The
company’s mission is to advance the care of patients suffering from
life-threatening diseases worldwide. Headquartered in Foster City, California,
Gilead has operations in North America, Europe and Asia Pacific.
For more information on Gilead Sciences, please visit www.gilead.com or call
the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences, Inc.
Patrick O’Brien, 650-522-1936
Press spacebar to pause and continue. Press esc to stop.